NOTE: This is a Forecasted Opportunity.
Visual acuity loss and blindness are significant public health problems, affecting more than 7 million people in the United States. Visual acuity loss is associated with a higher prevalence of comorbid conditions such as diabetes, cardiovascular disease, falls, injuries, depression, and premature mortality. Visual acuity loss, which can be prevented through early detection and timely treatment of common eye diseases, costs the nation more than $130 billion annually. The most common eye diseases that may cause irreversible vision loss include age-related macular degeneration, diabetic retinopathy, and glaucoma. Other treatable forms of vision loss, such as cataract and refractive errors, affect millions of Americans. These conditions are common and expected to increase over the next 30 years due to changing demographics in the U.S. population and an increase in risk factors such as diabetes. Eye diseases also contribute to health disparities in the population. Glaucoma, which affects more than 2.7 million individuals in the U.S., is the leading cause of irreversible blindness among African Americans. In addition, important social determinants of health contribute to these disparities in vision health. National and state data suggest that only about a half of those at high risk for serious vision loss had visited an eye doctor in the past year.
Surveillance of eye diseases and related topics is essential to track the magnitude of disease, associated risk factors, and social determinants of health, identify priority populations for intervention, set and monitor national objectives, and inform the development, implementation, and evaluation of public health strategies to support vision health. The purpose of this project is to maintain, enhance, and modernize CDC’s Vision and Eye Health Surveillance System (VEHSS), using valid and reliable data from a variety of sources, in order to assess U.S. national, state, and county-level prevalence of the major eye diseases, vision impairment, utilization of eye care services, and related risk factors and social determinants of health.
Estimated Post Date:
Jan 13, 2025
Estimated Application Due Date:
Mar 14, 2025
County governments
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Native American tribal governments (Federally recognized)
Special district governments
City or township governments
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
State governments
Eligible Countries:
Sponsor Institute/Organizations: Centers for Disease Control and Prevention
Sponsor Type:
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 14, 2025
Mar 14, 2025
$650,000
Affiliation: Centers for Disease Control and Prevention
Address: Centers for Disease Control and Prevention Office of Science Quality 1600 Clifton Road, NE Mail Stop D-72 Atlanta, Georgia 30333
Website URL: https://www.zintellect.com/Opportunity/Details/CDC-NCCDPHP-DHDSP-2024-0148
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.